NCT04240561

Brief Summary

This current translational project, funded by NIH, aims to better understand the impact of various signal modification strategies for older adults with Alzheimer's dementia and its potential precursor, known as amnestic mild cognitive impairment. The investigators hypothesize that adults with Alzheimer's dementia represent an extreme case of restricted cognitive ability, such that very low working memory capacity and overall reduced cognitive capacity will limit benefit from advanced signal processing. Thus, the investigators hypothesize that adults with Alzheimer's dementia will receive greater benefit from acoustically simple, high-fidelity hearing aid processing that minimally alters the acoustic signal.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
16mo left

Started Jul 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress79%
Jul 2021Aug 2027

First Submitted

Initial submission to the registry

January 10, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 27, 2020

Completed
1.4 years until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

6.2 years

First QC Date

January 10, 2020

Last Update Submit

April 28, 2026

Conditions

Keywords

mild cognitive impairment

Outcome Measures

Primary Outcomes (2)

  • Change In Speech Intelligibility (%Correct)

    Participants will listen to and repeat recorded low-context sentences presented at conversational level at varying levels of background noise. Scoring is determined by percentage of key words in each sentence a participant is able to hear and correctly repeat back to the tester. Scores may range from 0 to 100% and a higher score indicates better understanding (i.e. a better outcome).

    Change from Baseline to final appointment ineach hearing aid condition will be assessed. Participants will take an unaided baseline at the start of the trial. Measure will be repeated at the end of each intervention (3-5 weeks after each fitting).

  • Change in Conversation Analysis of Communication Breakdown

    Data will be extracted from conversation samples recorded between person with cognitive impairment and caregiver participants during a mealtime. Conversations will be audio recorded, transcribed ortho graphically and annotated for conversation breakdowns and repairs using Trouble-Source-Repair conventions grounded in Conversation Analysis approaches. Units of measure are: 1)Proportion of problematic talk 2) Proportion of trouble sources 3) Proportion of unsuccessful repairs and 4)Proportion of complex repairs. Reductions in all 4 reflect a positive change.

    Change from Baseline to final appointment in each hearing aid condition will be assessed. Participants will take an unaided baseline at the start of the trial. Measure will be repeated at the end of each intervention (3-5 weeks after each fitting).

Study Arms (2)

Hearing Aid Fitting Order A

EXPERIMENTAL

Participants wear hearing aids with a high level of signal manipulation, followed by a low level of signal manipulation

Device: High level of signal manipulationDevice: Low level of signal manipulation

Hearing Aid Fitting Order B

EXPERIMENTAL

Participants wear hearing aids with a low level of signal manipulation, followed by a high level of signal manipulation

Device: High level of signal manipulationDevice: Low level of signal manipulation

Interventions

Hearing aid will be programmed to a high level of signal manipulation.

Hearing Aid Fitting Order AHearing Aid Fitting Order B

Hearing aid will be programmed to a low level of signal manipulation.

Hearing Aid Fitting Order AHearing Aid Fitting Order B

Eligibility Criteria

Age50 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Speak English as their primary language
  • Normal or corrected to normal vision (20/40 binocular vision or unaided using a Snellen chart)
  • Sensorineural hearing loss with pure-tone thresholds 25-70 dB HL at octave frequencies between 500 and 3000 Hz and a 4 frequency (.5, 1, 2, 3 kHz) pure-tone average of greater than or equal to 30 dB in each ear
  • Clinical Dementia Rating (CDR) of 0.5 or 1 (indicating slight or mild cognitive impairment in the areas of memory, orientation, judgment/problem solving, community affairs, behavior at home/hobbies, and personal care)
  • Diagnosis of dementia Alzheimer's type or amnestic mild cognitive impairment (minimum MoCA score of 18).
  • Living at home
  • Minimum Grade 10 education
  • Able to provide own consent as evaluated by the Consent Assessment.

You may not qualify if:

  • Clinically significant unstable or progressive medical conditions, or conditions which, in the opinion of the investigator(s) places the participant at unacceptable risk if he or she were to participate in the study
  • History of unresolved communication difficulties following another neurological problem (e.g. stroke or brain tumor), neurodevelopmental disorder (e.g. Down's syndrome), or head/neck cancer
  • Positive history of major psychiatric disorder (e.g. schizophrenia, significant untreated depression)
  • Co-enrolled in other intervention studies targeting hearing, language, or communication strategies
  • Conductive hearing loss pathology, congenital hearing loss, or fluctuating hearing loss
  • Current active hearing aid wearer (defined as wearing hearing aid(s) at least 4 hours a day for most days within the past year)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Northwestern University

Chicago, Illinois, 60611, United States

RECRUITING

Northwestern University

Evanston, Illinois, 60208, United States

RECRUITING

MeSH Terms

Conditions

Hearing Loss, SensorineuralCognitive Dysfunction

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Pam Souza, PhD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants are randomly assigned to Hearing Aid fitting order A or B. One group will have the higher level of signal manipulation for the first session while the other group will start with the lower level of signal manipulation. Each group will then be given the other signal manipulation strategy. Outcome data will be collected by individuals blinded to which signal modification strategy the participant is using.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized cross-over Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair

Study Record Dates

First Submitted

January 10, 2020

First Posted

January 27, 2020

Study Start

July 1, 2021

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

August 31, 2027

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations